Both in Pharmaceuticals
Maravai LifeSciences Holdings vs MoonLake Immunotherapeutics
Over the past year MRVI returned +171.3% and MLTX returned +12.5%; their daily moves had a correlation of 0.11.
MRVI +171.3% MLTX +12.5%Growth of $1, one year, split-adjusted
| Metric | MRVI | MLTX |
|---|---|---|
| Price | $7.79 | $11.40 |
| Market cap | $1.16B | $970.2M |
| Today | +4.50% | −2.56% |
| 1 month | −0.8% | +4.1% |
| 6 months | +97.6% | −35.6% |
| Year to date | +139.5% | −13.5% |
| 1 year | +164.8% | +11.8% |
| Revenue growth (YoY) | +8.5% | — |
| Gross margin | 40.1% | — |
| Net margin | −24.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 5.6× | — |
| Net cash | -$106.6M | $437.5M |
| Dividend yield | — | — |
| Volatility (60d) | 86.4% | 57.1% |
| Short % of float | 10.7% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).